Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 16 October 2026.
Announcements
64
Total raised
£429M
disclosed amounts
The seed financing was supported by Unfold VC, Acquinox, and angel investors to expand the global reach of Monopoly World.
"This $4.7M seed round paves the way for Reality Games’ upcoming Series A, as we hope to reimagine Monopoly not just as a game but as a platform connecting players to real-world retail offers and experiences."
The seed round was provided by Hampshire investment firm Ridown Group to support the rollout of Echo AI.
"Echo AI exists to help teams become more efficient, ensuring they stay on track and don’t miss outcomes, action points, and context in meetings. Productivity can suffer when people lose track of meetings, fail to remember what was said and agreed, and are not clear about the actions they are responsible for. Echo AI takes all the guesswork out of it, giving everyone an accurate record of the meeting and what was agreed. Businesses which have used Echo AI tell us that it creates time, reduces misunderstandings and slip-ups, and helps keep teams focused on tasks."
The Series B round was led by NetmindAI with backing from WP Health.
"This successful round of funding is a clear validation of the market’s growing appetite for AI-powered hardware solutions. With the support of forward-thinking investors like NetMind.AI, we’re positioned to take our development and innovation in AI-driven hardware to new heights. This milestone not only fuels our ambition but also strengthens our commitment to delivering smarter, more intuitive technologies that transform human-machine interactions globally"
The funding comprises equity from Creative UK and angel investors alongside a grant from Innovate UK.
"We’re excited to support BeamXR with their innovative solution to enable live streaming from a standalone XR headset. We are looking forward to working with the founders as they build and grow this dynamic business."
The Series A financing was led by Par Equity to support international expansion and product development.
"Securing this investment allows us to scale our impact across healthcare and life sciences, with a focus on easing the burden of paediatric clinical trials. While legislation like RACE, SPCs, and the ODA has increased study numbers, specialist paediatric knowledge is still lacking in the industry. This has led to lower recruitment, adherence and trial completion rates compared to adult research. Little Journey is uniquely positioned to fill this expertise gap and tackle these challenges to advance global paediatric medicine. With the backing of Par Equity, Mercia Ventures, Octopus Ventures, and our wider investor network, we’re redefining how paediatric clinical trials are run and putting families at the heart of them."
